Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
391 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Anticoagulants"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance
Condition: Ischemic Stroke
Intervention: Drug: oral anticoagulants
2 Recruiting START-Register: Survey on Anticoagulated Patients Register
Conditions: Atrial Fibrillation;   Venous Thromboembolism;   Heart Valve Diseases or Prosthesis;   Other Heart or Peripheral Vascular Diseases Leading to Chronic Anticoagulation
Interventions: Drug: Anticoagulants;   Drug: anticoagulants
3 Not yet recruiting SILENT - Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial
Condition: Atrial Fibrillation
Intervention: Drug: anticoagulant by physician criteria
4 Not yet recruiting Safety and Efficacy Study of Apixaban to Prevent Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With PEG Asparaginase
Conditions: Lymphoma;   Acute Lymphoblastic Leukemia
Interventions: Drug: Apixaban;   Other: No systemic anticoagulant prophylaxis
5 Not yet recruiting Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events
Conditions: Anticoagulants;   Thromboembolism;   Hemorrhage
Interventions: Other: Measurement of Plasma Concentrations of NOACs;   Genetic: Identification of ABCB1 polymorphisms coding for P-gp
6 Recruiting Novel Oral Anticoagulants in Stroke Patients
Conditions: Ischemic Stroke,;   Intracranial Hemorrhage,
Intervention:
7 Recruiting Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs
Conditions: Myeloma;   Venous Thromboembolism
Intervention: Drug: Apixaban
8 Recruiting Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence
Conditions: Ischemic Stroke;   Patent Foramen Ovale;   Atrial Septal Aneurysm;   Migraine
Interventions: Drug: aspirin;   Drug: Antivitamins K;   Device: Devices for PFO closure
9 Unknown  Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Condition: Coronary Artery Disease
Interventions: Drug: clopidogrel + aspirin;   Drug: heparin + clopidogrel + aspirin;   Drug: enoxaparin + clopidogrel + aspirin;   Drug: bivalirudin + clopidogrel + aspirin
10 Recruiting Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant
Condition: Venous Thromboembolism
Intervention:
11 Unknown  Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education
Condition: Cardiac Surgery
Interventions: Behavioral: VKA (antivitamin K) education;   Behavioral: conventional hospital education
12 Recruiting Evaluation of the Duration of Therapy for Thrombosis in Children
Condition: Venous Thrombosis
Interventions: Other: Shortened duration (6 weeks) of anticoagulant therapy;   Other: Conventional duration (3 months) of anticoagulant therapy;   Other: No Intervention
13 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
Condition: Atrial Fibrillation
Interventions: Drug: Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban;   Drug: Vitamin K antagonist: warfarin, fluindione, acenocoumarol
14 Recruiting Perioperative Anticoagulant Use for Surgery Evaluation Study
Condition: Atrial Fibrillation
Intervention:
15 Recruiting Accuracy of a Portable International Normalized Ratio Monitor in Elderly Patients
Conditions: Blood Coagulation Disorders;   Blood Coagulation Disorder With Prolonged Bleeding Time;   Blood Coagulation Disorder With Prolonged Coagulation Time
Interventions: Device: INR capillary measurement with INRatio 2 device;   Other: antiphospholipid antibodies and lupus anticoagulant
16 Recruiting Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Condition: Idiopathic Venous Thromboembolism
Intervention: Other: Application of the"Men continue and HER DOO2" rule
17 Unknown  Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome
Intervention:
18 Recruiting Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Conditions: Venous Thromboembolism;   Atrial Fibrillation
Intervention: Other: complications and compliance with GIHP recommendations
19 Unknown  Reversal of the Antithrombotic Action of New Oral Anticoagulants
Conditions: Thrombosis;   Anticoagulant-induced Bleeding;   Anticoagulant Overdosage;   Hemorrhage
Interventions: Drug: Rivaroxaban;   Drug: Dabigatran
20 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years